Craig Gilgallon
Gründer bei Cingulate Works, Inc.
Vermögen: 6 830 $ am 31.05.2024
Aktive Positionen von Craig Gilgallon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | General Counsel | 01.01.2013 | - |
| Gründer | 01.01.2013 | - | |
| Unternehmenssekretär | 01.01.2013 | - | |
| Geschäftsführer | 01.03.2017 | 01.11.2017 | |
| Pawar Gilgallon & Rudy LLC | Corporate Officer/Principal | 01.01.2012 | - |
Karriereverlauf von Craig Gilgallon
Ehemalige bekannte Positionen von Craig Gilgallon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Compliance Officer | 01.01.2012 | 15.12.2023 |
| Gründer | - | 15.12.2023 | |
| General Counsel | 01.11.2012 | 15.12.2023 | |
| CINGULATE INC. | Gründer | 01.01.2013 | 15.12.2023 |
| General Counsel | 01.01.2013 | 15.12.2023 | |
| Unternehmenssekretär | 01.01.2013 | 15.12.2023 |
Ausbildung von Craig Gilgallon
| Thomas Jefferson School of Law | Graduate Degree |
| Ithaca College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Founder | 3 |
| General Counsel | 3 |
| Corporate Secretary | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CINGULATE INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
| Pawar Gilgallon & Rudy LLC |
- Börse
- Insiders
- Craig Gilgallon
- Erfahrung
